[go: up one dir, main page]

AR111569A1 - Combinaciones de lisobactina y aminoglucósidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos - Google Patents

Combinaciones de lisobactina y aminoglucósidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos

Info

Publication number
AR111569A1
AR111569A1 ARP180100377A ARP180100377A AR111569A1 AR 111569 A1 AR111569 A1 AR 111569A1 AR P180100377 A ARP180100377 A AR P180100377A AR P180100377 A ARP180100377 A AR P180100377A AR 111569 A1 AR111569 A1 AR 111569A1
Authority
AR
Argentina
Prior art keywords
gram
diseases caused
human animals
lisobactin
aminoglucosids
Prior art date
Application number
ARP180100377A
Other languages
English (en)
Inventor
Wolfgang Wiehl
Gert Daube
Stefan Flker
Guido Schiffer
Johannes Kbberling
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of AR111569A1 publication Critical patent/AR111569A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se refiere a la combinación de lisobactina con un antibiótico aminoglucósido para su uso en el tratamiento de enfermedades causadas por bacterias Gram positivas y Gram negativas en animales no humanos. Particularmente la presente puede tratar la mastitis bovina.
ARP180100377A 2017-02-17 2018-02-16 Combinaciones de lisobactina y aminoglucósidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos AR111569A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17156737.3A EP3363452A1 (en) 2017-02-17 2017-02-17 Combinations of lysobactin and aminogylcosides against diseases caused by gram-positive and gram-negative bacteria in non-human animals

Publications (1)

Publication Number Publication Date
AR111569A1 true AR111569A1 (es) 2019-07-31

Family

ID=58098497

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180100377A AR111569A1 (es) 2017-02-17 2018-02-16 Combinaciones de lisobactina y aminoglucósidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos

Country Status (16)

Country Link
US (2) US20200230204A1 (es)
EP (2) EP3363452A1 (es)
JP (1) JP6655771B1 (es)
KR (1) KR102123599B1 (es)
CN (1) CN110234338A (es)
AR (1) AR111569A1 (es)
AU (1) AU2018222615B2 (es)
BR (1) BR112019017010A2 (es)
CA (1) CA3053608C (es)
ES (1) ES2893927T3 (es)
MX (1) MX380684B (es)
NZ (1) NZ755710A (es)
RU (1) RU2760008C2 (es)
TW (1) TWI783969B (es)
UY (1) UY37607A (es)
WO (1) WO2018149871A1 (es)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
US4172138A (en) * 1977-03-23 1979-10-23 Rhodes Russell E Method and composition of matter for the treatment of dry cows for mastitis
CA1266247A (en) 1985-03-25 1990-02-27 Adrienne A. Tymiak Antibiotic prepared from lysobacter sp. sc 14,067
JPH01132600A (ja) 1987-11-17 1989-05-25 Shionogi & Co Ltd カタノシンａおよびｂならびにその製造法
DE10320781A1 (de) 2003-05-09 2004-11-25 Bayer Healthcare Ag Acylierte Nonadepsipeptide
US20050191270A1 (en) * 2004-02-27 2005-09-01 Hydromer, Inc. Anti-infectious hydrogel compositions
DE102004051024A1 (de) 2004-10-20 2006-04-27 Bayer Healthcare Ag Heterocyclyl-substituierte Nonadepsipeptide
DE102004051025A1 (de) 2004-10-20 2006-04-27 Bayer Healthcare Ag Substituierte Nonadepsipeptide
DE102004051023A1 (de) 2004-10-20 2006-05-04 Bayer Healthcare Ag Desoxo-Nonadepsipeptide
DE102004053410A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Cyclische Nonadepsipeptidamide
DE102004053409A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Verfahren zur gezielten Herstellung von Lysobactinfragmenten
DE102004053407A1 (de) * 2004-11-05 2006-05-11 Bayer Healthcare Ag Acylierte Nonadepsipeptide II
DE102006003443A1 (de) 2006-01-25 2007-07-26 Aicuris Gmbh & Co. Kg Asparagin-10-substituierte Nonadepsipeptide
DE102006018250A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Verfahren zum Herstellen von cyclischen Depsipeptiden
DE102006018080A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Lysobactinamide
JP6335185B2 (ja) * 2012-12-03 2018-05-30 ノボバイオティック ファーマシューティカルズ， エルエルシー 新規デプシペプチドおよびその使用

Also Published As

Publication number Publication date
AU2018222615A1 (en) 2019-08-08
US20200230204A1 (en) 2020-07-23
EP3548059A1 (en) 2019-10-09
CN110234338A (zh) 2019-09-13
TW201834662A (zh) 2018-10-01
JP2020508299A (ja) 2020-03-19
US20220000969A1 (en) 2022-01-06
RU2760008C2 (ru) 2021-11-22
RU2019129026A3 (es) 2021-03-17
JP6655771B1 (ja) 2020-02-26
BR112019017010A2 (pt) 2020-04-14
CA3053608A1 (en) 2018-08-23
MX380684B (es) 2025-03-12
UY37607A (es) 2018-09-28
EP3363452A1 (en) 2018-08-22
AU2018222615B2 (en) 2020-07-23
RU2019129026A (ru) 2021-03-17
CA3053608C (en) 2020-09-15
NZ755710A (en) 2022-04-29
TWI783969B (zh) 2022-11-21
KR102123599B1 (ko) 2020-06-16
KR20190097293A (ko) 2019-08-20
ES2893927T3 (es) 2022-02-10
EP3548059B1 (en) 2021-07-21
MX2019009573A (es) 2019-10-02
WO2018149871A1 (en) 2018-08-23

Similar Documents

Publication Publication Date Title
BR112018005318A2 (pt) ?polipeptídeos de lisina ativos contra bactérias gram-negativas?
PE20191356A1 (es) Suministro de proteinas basado en bacterias con virulencia atenuada
CL2017002176A1 (es) Identificación bacteriana y prueba de susceptibilidad antimicrobiana.
CL2019002135A1 (es) Células microbianas, métodos para producir las mismas, y usos de las mismas.
BR112017009584A2 (pt) tratamento de retinite pigmentosa com n-acetilcisteína amida
MX2016009898A (es) Tratamientos para acne resistente.
SV2017005462A (es) Compuestos de isoxazol de ácido hidroxámico como inhibidores de lpxc
ECSP20084373A (es) Tiofencarboxamidas sustituidas y análogos de las mismas
MX2018012003A (es) Composiciones producidas por microorganismos con actividad estimuladora sobre las plantas.
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
NZ728429A (en) Acinetobacter lysins
MX2019009908A (es) Combinacion de un agonista de ppar con un agonista de fxr.
CO2017010271A2 (es) Archaebacteria en alimento para animales bioactivo, método para hacer la composición y métodos que emplean la composición
MX376475B (es) Derivado de polimixina y usos del mismo.
AR095594A1 (es) Métodos para tratar infecciones en pacientes con sobrepeso y obesos usando antibióticos
MX2015015127A (es) Enzimas para alimentacion animal.
PH12014501239A1 (en) Thymol and totarol antibacterial composition
BR112018067967A2 (pt) tratamento de pacientes com hipercolesterolemia familiar homozigótica por meio de terapia hipolipemiante
AR111569A1 (es) Combinaciones de lisobactina y aminoglucósidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos
CR20190466A (es) Tratamiento de una infección vaginal bacteriana
BR112021026797A2 (pt) Composição alimentar para animais
MX2017004632A (es) Mejoras en y relacionadas con el tratamiento del agua, en particular para inhibir el crecimiento de microorganismos.
MX2021007599A (es) Composiciones probióticas listas para utilizar y usos de las mismas.
ECSP18060284A (es) Tratamiento para microorganismos que contienen quitina
CO2019006311A2 (es) N-acetilcisteína para su uso como agente antibacteriano

Legal Events

Date Code Title Description
FG Grant, registration